1-8 of 8
Constantine S. Mitsiades
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Accessory Cells of the Microenvironment Protect Multiple Myeloma from T-Cell Cytotoxicity through Cell Adhesion-Mediated Immune Resistance

Free
Sanne J. de Haart, Niels W.C.J. van de Donk, Monique C. Minnema, Julie H. Huang, Tineke Aarts-Riemens, Niels Bovenschen, Huipin Yuan, Richard W.J. Groen, Douglas W. McMillin, Jana Jakubikova, Henk M. Lokhorst, Anton C. Martens, Constantine S. Mitsiades, Tuna Mutis
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (20): 5591–5601.
https://doi.org/10.1158/1078-0432.CCR-12-3676
Published: 14 October 2013
View articletitled, Accessory Cells of the Microenvironment Protect Multiple Myeloma from T-Cell Cytotoxicity through Cell Adhesion-Mediated Immune Resistance
Open the PDF for Accessory Cells of the Microenvironment Protect Multiple Myeloma from T-Cell Cytotoxicity through Cell Adhesion-Mediated Immune Resistance in another window
Includes: Supplementary data
Journal Articles

Treatment Options for Relapsed and Refractory Multiple Myeloma

Free
Sagar Lonial, Constantine S. Mitsiades, Paul G. Richardson
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (6): 1264–1277.
https://doi.org/10.1158/1078-0432.CCR-10-1805
Published: 15 March 2011
View articletitled, Treatment Options for Relapsed and Refractory Multiple Myeloma
Open the PDF for Treatment Options for Relapsed and Refractory Multiple Myeloma in another window
Journal Articles

Phase II Clinical and Pharmacokinetic Study of Plitidepsin 3-Hour Infusion Every Two Weeks Alone or with Dexamethasone in Relapsed and Refractory Multiple Myeloma

Free
María Victoria Mateos, Maria Teresa Cibeira, Paul G. Richardson, Felipe Prosper, Albert Oriol, Javier de la Rubia, Juan José Lahuerta, Ramón García-Sanz, Sonia Extremera, Sergio Szyldergemajn, Claudia Corrado, Harald Singer, Constantine S. Mitsiades, Kenneth C. Anderson, Joan Bladé, Jesús San Miguel
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (12): 3260–3269.
https://doi.org/10.1158/1078-0432.CCR-10-0469
Published: 14 June 2010
View articletitled, Phase II Clinical and Pharmacokinetic Study of Plitidepsin 3-Hour Infusion Every Two Weeks Alone or with Dexamethasone in Relapsed and Refractory Multiple Myeloma
Open the PDF for Phase II Clinical and Pharmacokinetic Study of Plitidepsin 3-Hour Infusion Every Two Weeks Alone or with Dexamethasone in Relapsed and Refractory Multiple Myeloma in another window
Journal Articles

Interactions of the Hdm2/p53 and Proteasome Pathways May Enhance the Antitumor Activity of Bortezomib

Free
Melissa G. Ooi, Patrick J. Hayden, Vassiliki Kotoula, Douglas W. McMillin, Elpida Charalambous, Emily Daskalaki, Noopur S. Raje, Nikhil C. Munshi, Dharminder Chauhan, Teru Hideshima, Leutz Buon, Martin Clynes, Peter O'Gorman, Paul G. Richardson, Constantine S. Mitsiades, Kenneth C. Anderson, Nicholas Mitsiades
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (23): 7153–7160.
https://doi.org/10.1158/1078-0432.CCR-09-1071
Published: 30 November 2009
View articletitled, Interactions of the Hdm2/p53 and Proteasome Pathways May Enhance the Antitumor Activity of Bortezomib
Open the PDF for Interactions of the Hdm2/p53 and Proteasome Pathways May Enhance the Antitumor Activity of Bortezomib in another window
Includes: Supplementary data
Journal Articles

Preclinical Studies in Support of Defibrotide for the Treatment of Multiple Myeloma and Other Neoplasias

Free
Constantine S. Mitsiades, Cecile Rouleau, Cinara Echart, Krishna Menon, Beverly Teicher, Maria Distaso, Antonio Palumbo, Mario Boccadoro, Kenneth C. Anderson, Massimo Iacobelli, Paul G. Richardson
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (4): 1210–1221.
https://doi.org/10.1158/1078-0432.CCR-08-1270
Published: 19 February 2009
View articletitled, Preclinical Studies in Support of Defibrotide for the Treatment of Multiple Myeloma and Other Neoplasias
Open the PDF for Preclinical Studies in Support of Defibrotide for the Treatment of Multiple Myeloma and Other Neoplasias in another window
Includes: Supplementary data
Journal Articles

Fas Signaling in Thyroid Carcinomas Is Diverted from Apoptosis to Proliferation

Free
Constantine S. Mitsiades, Vassiliki Poulaki, Galinos Fanourakis, Elias Sozopoulos, Douglas McMillin, Zhaoqin Wen, Gerassimos Voutsinas, Sophia Tseleni-Balafouta, Nicholas Mitsiades
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (12): 3705–3712.
https://doi.org/10.1158/1078-0432.CCR-05-2493
Published: 15 June 2006
View articletitled, Fas Signaling in Thyroid Carcinomas Is Diverted from Apoptosis to Proliferation
Open the PDF for Fas Signaling in Thyroid Carcinomas Is Diverted from Apoptosis to Proliferation in another window
Journal Articles

Novel Histone Deacetylase Inhibitors in the Treatment of Thyroid Cancer

Free
Constantine S. Mitsiades, Vassiliki Poulaki, Ciaran McMullan, Joseph Negri, Galinos Fanourakis, Athina Goudopoulou, Victoria M. Richon, Paul A. Marks, Nicholas Mitsiades
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (10): 3958–3965.
https://doi.org/10.1158/1078-0432.CCR-03-0776
Published: 16 May 2005
View articletitled, Novel Histone Deacetylase Inhibitors in the Treatment of Thyroid Cancer
Open the PDF for Novel Histone Deacetylase Inhibitors in the Treatment of Thyroid Cancer in another window
Journal Articles

Combination of Somatostatin Analog, Dexamethasone, and Standard Androgen Ablation Therapy in Stage D3 Prostate Cancer Patients with Bone Metastases

Free
Michael Koutsilieris, Constantine S. Mitsiades, John Bogdanos, Theodoros Dimopoulos, Dimitrios Karamanolakis, Constantine Milathianakis, Athanassios Tsintavis
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (13): 4398–4405.
https://doi.org/10.1158/1078-0432.CCR-04-0077
Published: 06 July 2004
View articletitled, Combination of Somatostatin Analog, Dexamethasone, and Standard Androgen Ablation Therapy in Stage D3 Prostate Cancer Patients with Bone Metastases
Open the PDF for Combination of Somatostatin Analog, Dexamethasone, and Standard Androgen Ablation Therapy in Stage D3 Prostate Cancer Patients with Bone Metastases in another window